This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Halin, S. Articles by Bergh, A. Search for Related Content PubMed PubMed Citation Articles by Halin, S. Articles by Bergh, A.

Decreased Pigment Epithelium-Derived Factor Is Associated with Metastatic Phenotype in Human and Rat Prostate Tumors

¹ Departments of Medical Biosciences, Pathology and ² Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden; ³ Department of Pathology, Northwestern University Medical School, Chicago, Illinois; and ⁴ Robert H. Lurie Comprehensive Cancer Center, Northwestern University Medical School, Chicago, Illinois

Pigment epithelium-derived factor, a potent angiogenesis inhibitor in the eye, is also expressed in the prostate. Prostate size and angiogenesis is increased in pigment epithelium-derived factor knockout mice, and pigment epithelium-derived factor is down-regulated in some prostate cancers. To investigate whether pigment epithelium-derived factor expression correlates with tumor progression, we examined 5 Dunning rat prostate sublines with different growth rates, differentiation, androgen dependence, vascular density, and metastatic ability and 26 human prostate cancers of Gleason score 8–10 obtained from patients at transurethral resection selected to represent two groups, with and without metastases at diagnosis. By Western blot, real-time quantitative reverse transcription-PCR, and immunostaining, pigment epithelium-derived factor was detected in highly differentiated, nonmetastatic, androgen-sensitive Dunning tumors and in the anaplastic, androgen insensitive but nonmetastatic Dunning tumors. In contrast, the metastatic Dunning tumor sublines showed very low pigment epithelium-derived factor expression levels. In human cancer tissues, by immunohistochemistry and real-time quantitative reverse transcription-PCR, patients without metastases at diagnosis had higher tumor pigment epithelium-derived factor levels than tumors from patients with metastases at diagnosis. In both the rat model and in the human tumors, the proliferation index and vascular count, as determined by Ki-67 staining and endoglin and/or factor VIII-related antigen staining, inversely correlated with pigment epithelium-derived factor mRNA levels. These observations indicate that loss of pigment epithelium-derived factor expression could be associated with the progression toward a metastatic phenotype in prostate cancer.

This article has been cited by other articles:

				W-Y. Hsieh, M-W. Chen, H-T. Ho, T-M. You, and Y-T. Lu Identification of differentially expressed proteins in human malignant pleural effusions Eur. Respir. J., December 1, 2006; 28(6): 1178 - 1185. [Abstract] [Full Text] [PDF]

				L. W. T. Cheung, S. C. L. Au, A. N. Y. Cheung, H. Y. S. Ngan, J. Tombran-Tink, N. Auersperg, and A. S. T. Wong Pigment Epithelium-Derived Factor Is Estrogen Sensitive and Inhibits the Growth of Human Ovarian Cancer and Ovarian Surface Epithelial Cells Endocrinology, September 1, 2006; 147(9): 4179 - 4191. [Abstract] [Full Text] [PDF]

				E. T.H. Ek, C. R. Dass, and P. F.M. Choong Pigment epithelium-derived factor: a multimodal tumor inhibitor. Mol. Cancer Ther., July 1, 2006; 5(7): 1641 - 1646. [Abstract] [Full Text] [PDF]

				J. Cai, C. Parr, G. Watkins, W. G. Jiang, and M. Boulton Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin. Cancer Res., June 1, 2006; 12(11): 3510 - 3517. [Abstract] [Full Text] [PDF]

				S. Filleur, K. Volz, T. Nelius, Y. Mirochnik, H. Huang, T. A. Zaichuk, M. S. Aymerich, S. P. Becerra, R. Yap, D. Veliceasa, et al. Two Functional Epitopes of Pigment Epithelial-Derived Factor Block Angiogenesis and Induce Differentiation in Prostate Cancer Cancer Res., June 15, 2005; 65(12): 5144 - 5152. [Abstract] [Full Text] [PDF]